Form 4 for ACHC Acadia Healthcare Company, Inc.
Accepted 2023-02-23 00:00:00 ET · period of report 2023-02-21 · accession 0000899243-23-006015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-02-23 | 2023-02-21 | ACHC | Harrod Laurence L. | EVP of Fin | A - Grant | $0.00 | +197.2K | 287.3K | +219% | $0 |
| 2023-02-23 | 2023-02-21 | ACHC | Harrod Laurence L. | EVP of Fin | F - Tax | $80.87 | -73.6K | 219.6K | -25% | -$5.96M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-21 | A | A | 5,925 | $0.00 | 293,251 | D | — | — | (F2) Shares earned based on 2022 performance under performance vesting restricted stock units awarded on April 11, 2022. The shares will not be issued until the end of the three-year period under the restricted stock unit award. |
| 2 | Common | Common Stock | 2023-02-21 | A | A | 191,301 | $0.00 | 287,326 | D | — | — | (F1) Shares received upon vesting of performance vesting restricted stock units awarded on March 24, 2020. |
| 3 | Common | Common Stock | 2023-02-21 | F | D | 73,643 | $80.87 | 219,608 | D | — | — |